‘
When a patient walks into your clinic asking whether there is a drug-free option for managing osteoporosis or osteopenia, a clear answer matters. Low-intensity vibration for clinical use has become a frequent topic among physiotherapists, chiropractors, naturopaths, and other practitioners across Canada as patients research alternatives to bisphosphonates and other bone-loss medications. This post looks at what the clinical evidence shows, how the technology works at a cellular level, and what to consider before referring a patient to a medically certified device such as Marodyne LiV.
The Research Behind Low-Intensity Vibration for Clinical Use
Marodyne LiV traces its origins to NASA-funded research into astronaut bone loss during extended time in zero gravity. Led by Professor Clinton Rubin, a biomedical engineer and SUNY Distinguished Professor at Stony Brook University, the research that became Marodyne LiV has been supported by the National Institutes of Health (NIH), NASA, and other international bodies over nearly four decades. The findings have been published in peer-reviewed literature and continue to be reviewed by a scientific advisory board with expertise in biomedicine, orthopaedics, osteoporosis, and rehabilitation medicine.
Marodyne LiV itself is certified under the European Union Medical Device Directive. That distinguishes it from consumer vibration plates, which are built for fitness rather than bone stimulation. Marodyne LiV delivers a specific low-amplitude, low-frequency signal of 0.3g at 30Hz, calibrated for the mechanical thresholds associated with bone cell response rather than muscular exertion. This is a meaningful distinction to raise with patients who may have already tried a general-purpose vibration plate and assumed the two technologies were interchangeable.
How Mechanical Stimulation Supports Bone Density
The underlying principle is mechanotransduction: bone tissue responds to consistent, low-level mechanical loading by activating osteoblast activity. Standing on a low-intensity vibration platform for 10 to 20 minutes a day delivers this stimulus without the joint impact associated with higher-intensity exercise, which can make it a reasonable option for patients managing pain, reduced mobility, or fall risk.
For patients dealing with age-related muscle loss or postural instability, low-intensity vibration may also help support muscle strength and balance, both of which factor into fracture prevention alongside bone density itself. This can be a relevant consideration for patients managing sarcopenia or reduced mobility who are not well suited to higher-intensity weight-bearing exercise programs. It is worth noting to patients that this is a supportive technology, not a substitute for their prescribed medical treatment plan.
Identifying Patients Who May Benefit From Referral
Appropriate candidates typically include patients diagnosed with osteoporosis or osteopenia, those raising concerns about the side effects of long-term medication use, and patients at elevated risk of falls due to reduced muscle strength or balance. Frail or postmenopausal patients, and those recovering from orthopaedic surgery, are also commonly referred, since the device requires only standing on the platform with no added joint load. Because Marodyne LiV is non-invasive and has no known contraindications with commonly prescribed osteoporosis medications, it is generally considered safe to use alongside an existing treatment plan, though patients should always be encouraged to confirm this with their own care team.
Our Healthcare Professionals page outlines patient profiles in more detail and includes the referral information your clinic will need.
What a Referral Looks Like in Practice
A prescription is not required for a patient to purchase Marodyne LiV, but a prescription from a physician, nurse practitioner, physiotherapist, or chiropractor may help a patient save the GST on their purchase and can support a private insurance claim. The device ships directly across Canada, and our team is available to answer questions from both patients and referring practitioners throughout the process.
Frequently Asked Questions for Healthcare Professionals
Is there clinical evidence to support recommending low-intensity vibration for osteoporosis?
Yes. Marodyne LiV is built on nearly 40 years of research funded in part by NIH and NASA, and the device is certified under the European Union Medical Device Directive. The technology has been studied specifically for its effect on bone density and postural stability in postmenopausal women and other at-risk populations.
Can Marodyne LiV be used alongside prescribed osteoporosis medication?
Many patients use Marodyne LiV alongside medications such as bisphosphonates. There are no known contraindications, though patients should discuss this with their prescribing physician or pharmacist to confirm it fits their individual care plan.
What patient profiles are best suited for a referral?
Patients diagnosed with osteoporosis or osteopenia, those looking for a non-pharmacological complement to their current treatment, and those at higher risk of falls due to reduced muscle strength or balance concerns are generally well-suited.
Does a patient need a prescription to access Marodyne LiV?
No. A prescription is not required to purchase the device, though one from a physician, nurse practitioner, physiotherapist, or chiropractor may help reduce cost through GST savings and support an insurance claim.
How can my clinic get in touch with the Marodyne LiV team?
You can reach Marodyne directly to discuss referrals, ask technical questions, or request more information for your patients.
Partner With Our Team
If you would like to learn more about referring patients or want technical details to share with your practice, our team is ready to help.
For practitioners fielding questions about drug-free bone health options, low-intensity vibration offers a clinically supported avenue worth understanding. Marodyne LiV combines decades of research with a straightforward at-home routine, giving your patients another tool to discuss as part of their broader care plan.

